Pfreundschuh M, Röhrich M, Piotrowksi W, Penzholz H, Fischer H
Anticancer Res. 1981;1(6):367-72.
Sera of 32 patients with meningioma were tested for reactivity to cell surface antigens of autologous meningioma cells with protein-A assay (PA), immune adherence assay (IA), and anti-C 3-mixed hemadsorption assay (C3-MHA). Antibodies against autologous meningioma could be detected in 6/32 patients by PA, in about half the patients by IA and in almost all patients by C3-MHA with titers ranging from 1:2 to 1:28. Only the serum reactivity detected by C3-MHA was high enough for analysis of the specificity of the reaction by absorption tests. By absorption with a panel of autologous, allogeneic and heterologous cells we were unable to demonstrate a meningioma-specific antigen. Most autologous sera detected oncofetal antigens. Serum reactivity to autologous meningioma showed no correlation to antibodies to SV-40.
采用蛋白A试验(PA)、免疫粘连试验(IA)和抗C3混合血细胞吸附试验(C3-MHA)检测了32例脑膜瘤患者血清对自体脑膜瘤细胞表面抗原的反应性。通过PA可在6/32例患者中检测到抗自体脑膜瘤抗体,IA可在约半数患者中检测到,C3-MHA则在几乎所有患者中均可检测到,滴度范围为1:2至1:28。只有C3-MHA检测到的血清反应性高到足以通过吸收试验分析反应的特异性。通过用一组自体、同种异体和异种细胞进行吸收,我们未能证明存在脑膜瘤特异性抗原。大多数自体血清检测到癌胚抗原。血清对自体脑膜瘤的反应性与抗SV-40抗体无相关性。